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Abstract
Aims/hypothesis. Increased intra-abdominal fat is as-
sociated with insulin resistance and an atherogenic li-
poprotein profile. Circulating concentrations of adip-
onectin, an adipocyte-derived protein, are decreased
with insulin resistance. We investigated the relation-
ships between adiponectin and leptin, body fat distri-
bution, insulin sensitivity and lipoproteins.
Methods. We measured plasma adiponectin, leptin and
lipid concentrations, intra-abdominal and subcutane-
ous fat areas by CT scan, and insulin sensitivity index
(SI) in 182 subjects (76 M/106F).
Results. Adiponectin concentrations were higher in
women than in men (7.4±2.9 vs 5.4±2.3 µg/ml,
p<0.0001) as were leptin concentrations (19.1±13.7 vs
6.9±5.1 ng/ml, p<0.0001). Women were more insulin
sensitive (SI: 6.8±3.9 vs 5.9±4.4×10−5 min−1/(pmol/l),
p<0.01) and had more subcutaneous (240±133 vs
187±90 cm2, p<0.01), but less intra-abdominal fat
(82±57 vs 124±68 cm2, p<0.0001). By simple regres-
sion, adiponectin was positively correlated with age
(r=0.227, p<0.01) and SI (r=0.375, p<0.0001), and nega-
tively correlated with BMI (r=−0.333, p<0.0001), subcu-
taneous (r=−0.168, p<0.05) and intra-abdominal fat 
(r=−0.35, p<0.0001). Adiponectin was negatively corre-
lated with triglycerides (r=−0.281, p<0.001) and posi-
tively correlated with HDL cholesterol (r=0.605,
p<0.0001) and Rf, a measure of LDL particle buoyancy
(r=0.474, p<0.0001). By multiple regression analysis,
adiponectin was related to age (p<0.0001), sex (p<0.005)
and intra-abdominal fat (p<0.01). SI was related to intra-
abdominal fat (p<0.0001) and adiponectin (p<0.0005).
Both intra-abdominal fat and adiponectin contributed in-
dependently to triglycerides, HDL cholesterol and Rf.
Conclusion/interpretation. These data suggest that ad-
iponectin concentrations are determined by intra-ab-
dominal fat mass, with additional independent effects
of age and sex. Adiponectin could link intra-abdomi-
nal fat with insulin resistance and an atherogenic lipo-
protein profile. [Diabetologia (2003) 46:459–469]
Keywords Adiponectin, Acrp30, adipoQ, central obe-
sity, subcutaneous fat, intra-abdominal fat, insulin
sensitivity, lipids, hepatic lipase, cardiovascular dis-
ease, leptin.
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It is well recognized that obesity and insulin resistance
are closely related [1, 2, 3, 4]. Android body fat distri-
bution is associated with insulin resistance more than
is a gynoid body fat distribution [5], with the site of
abdominal fat distribution being an additional deter-
minant of insulin sensitivity [6, 7, 8, 9, 10, 11]. We
found in both lean and obese subjects that the intra-
abdominal fat (IAF) depot is a stronger determinant of
insulin sensitivity than the subcutaneous fat (SCF) de-
pot [11], while SCF is the main determinant of the
plasma concentration of leptin [11], an adipocyte-de-
rived hormone regulating energy metabolism [12, 13].
There is great interest in the relationship between
body fat distribution and insulin sensitivity due to
their role in cardiovascular disease and Type 2 diabe-
tes, but the mediators of this interaction between
body fat and insulin sensitivity remain uncertain. A
role has been suggested for NEFA as they are com-
monly increased in states associated with insulin re-
sistance [14, 15, 16] and induce insulin resistance in
vivo and in vitro [15, 16]. The lipolytically more ac-
tive intra-abdominal fat [17] is an important source of
NEFA in the portal circulation, draining them directly
to the liver and thereby altering hepatic glucose and
lipid metabolism [18, 19, 20]. Recently, it has been
shown in mice fed a high fat, high sucrose diet that
administration of the recently characterized adipocyte
secreted protein adiponectin increases fat oxidation,
thereby reducing NEFA concentrations and body
weight [21].
Adiponectin, also known as apM1 [22], Acrp30
[23], GBP28 [24] or adipoQ [25], has been suggested
to be an important regulator of insulin action, thereby
possibly linking adiposity and insulin sensitivity [26,
27]. Unlike many of the other “adipokines” such as tu-
mour necrosis factor-α (TNF-α), leptin and resistin
that increase with adiposity [13], circulating adiponec-
tin concentrations are reduced in individuals who are
obese [28, 29, 30, 31], have cardiovascular disease
[32] or Type 2 diabetes [29]. Circulating adiponectin
concentrations are correlated with insulin sensitivity
[30, 31], with low concentrations predicting a future
decrease in insulin sensitivity in Pima Indians [33].
Furthermore, low adiponectin concentrations have
been associated with a more atherogenic lipid profile
[34] and have been shown to increase with thiazoli-
dinedione administration [35, 36]. Studies in animals
also suggest that adiponectin could be an important
determinant of insulin action. Thus, a decline in adip-
onectin concentrations has been shown to coincide
with the development of hyperinsulinaemia and insu-
lin resistance in obese rhesus monkeys [37] while both
heterozygous and homozygous adiponectin null mice
have a phenotype of insulin resistance with a gene
dose effect [38] and develop marked diet-induced in-
sulin resistance [39].
Based on these observations, we hypothesized that
central adiposity and specifically visceral adiposity is
an important determinant of adiponectin and could be
important in linking adiposity to insulin sensitivity.
Therefore, we examined the relationships of adiponec-
tin concentrations with insulin sensitivity, body fat
distribution and lipids in a large cohort of apparently
healthy human subjects in whom we have rigorously
quantified these parameters. The questions we posed
were the following: (i) Are adiponectin concentrations
related to body fat distribution and if so, is one ab-
dominal fat depot more strongly related to adiponectin
than another? (ii) Are adiponectin concentrations re-
lated to an atherogenic lipid profile and if so, to which
lipoprotein measure? (iii) Do age and sex have an im-
pact on these relationships?
Subjects and Methods
Subjects. We recruited 182 individuals (76 men/106 women)
aged 32 to 75 years by advertisement, from the Greater Seattle
area, to participate in a study on the effect of insulin sensitivity
on the lipoprotein profile response to egg consumption [40].
Eligible subjects had to be apparently healthy with no known
history of diabetes, coronary artery disease or other vascular
disease. In addition, they could not be receiving treatment for
lipid disorders or hypertension and had to be free of renal or
hepatic disease. At the time of screening, qualifying individu-
als had to have a fasting plasma glucose less than 6.4 mmol/l,
LDL cholesterol less than 4.9 mmol/l and triglycerides less
than 5.7 mmol/l. The study was reviewed and approved by the
Human Subjects Review Committee at the University of Wash-
ington and written informed consent was obtained from all
subjects. All data shown in this analysis are baseline measure-
ments carried out at the start of the study.
Characterization of body size and fat distribution. Body mass
index (BMI) was calculated as weight (kg)/[height (m)]2. The
waist-to-hip ratio was calculated as waist circumference
(cm)/hip circumference (cm) [41].
A computed tomography (CT) scan at the level of the um-
bilicus was used to quantify SCF and IAF areas [42]. For this
purpose, the border of the intra-abdominal cavity was outlined
on the CT image and total fat and IAF areas were quantified by
selecting an attenuation range of –250 to −50 Hounsfield units.
SCF area was calculated as the difference between total fat 
area and IAF area. The variability of these measures made by a
single observer is 1.5% and day to day variability is less than
1% [43].
Insulin sensitivity. Insulin sensitivity was quantified as the in-
sulin sensitivity index (SI) using Bergman’s minimal model of
glucose kinetics [44]. For this purpose, the glucose and insulin
data obtained during a frequently sampled intravenous glucose
tolerance test modified by the injection of tolbutamide were
analyzed [45, 46]. The day to day variability of SI in our labo-
ratory is 16.9% [47].
Chemical analyses. All analyses were carried out on blood
samples drawn after an overnight fast of at least 12 h and were
stored at −70°C until assayed. All samples were then measured
in duplicate in each assay. Plasma glucose concentrations were
measured using the glucose oxidase method. Immunoreactive
insulin concentrations were measured in plasma by radioim-
munoassay using a modification of a double antibody method
[48]. Plasma leptin concentrations were also measured by ra-
dioimmunoassay (Linco Research, St. Louis Mo., USA) [49].
Plasma adiponectin concentrations were measured using a
radioimmunoassay for human adiponectin (Linco Research).
The assay utilizes 125I-labelled adiponectin and an anti-adip-
onectin rabbit antiserum to measure adiponectin concentrations
by the double antibody/PEG technique. Standards over the
range of 1 to 200 ng/ml were prepared using recombinant hu-
man adiponectin. All plasma samples were diluted 1:200 yield-
ing an effective range of 0.2 to 40 µg/ml. The intra-assay and
inter-assay coefficients of variation at adiponectin concentra-
tions in the range of 3 to 15 µg/ml are 1.8 to 6.2% and 6.9 to
9.3%, respectively. Plasma adiponectin concentrations mea-
sured in 40 paired samples using this assay and ELISA [28]
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were similar (10.4±6.6 vs 10.1±5.5 µg/ml) and linearly related
(r=0.896, p<0.0001; M.K. Sinha, unpublished observation).
Plasma triglycerides and total cholesterol were measured by
enzymatic analytical chemistry. HDL cholesterol was precipi-
tated using dextran-sulphate and measured enzymatically. The
LDL cholesterol concentration was calculated using the
Friedewald equation: LDL cholesterol=total cholesterol−HDL
cholesterol−(triglycerides/5). Apolipoprotein B (apoB) was
measured by nephelometry [50] and non-equilibrium density
gradient ultracentrifugation (DGUC) was carried out with the
collection of 38 fractions in which cholesterol was measured
[51]. The LDL relative flotation index (Rf), a measure of LDL
particle buoyancy, was measured by dividing the fraction num-
ber containing the highest LDL cholesterol concentration by
38, the latter representing the total number of fractions sam-
pled. Lipoprotein measures were carried out in only 170 sub-
jects with Rf not being measured in an additional eight individ-
uals.
Statistical analyses. Data are expressed as means ± SD. Nor-
mality of distribution of the data was tested by the Kolmogo-
rov-Smirnov test, a p value greater than 0.05 indicated that the
observed distribution of a variable is not statistically different
from the normal distribution. Comparison of demographic and
metabolic variables by sex was done by unpaired t test and by
Mann-Whitney U test when the data were not normally distrib-
uted. The relative contribution of age, sex and abdominal fat
compartments was examined by analyses of subgroups of men
and women and of young and older subjects. These subject
groups were matched for IAF by pairwise selection of individ-
uals with IAF differing by less than or equal to 10 cm2 and
were then compared by unpaired t tests or Mann-Whitney U
tests.
Scatterplots were used to visually evaluate the relationships
between continuous variables in the whole cohort of 182 sub-
jects and when subdivided by sex. Correlations were done by
linear regression. Multiple regression analysis was used to de-
termine whether the association between the dependent and in-
dependent variables of interest remained significant after ad-
justing for other potentially confounding independent vari-
ables. For this analysis, the dependent variables were natural
log (loge) transformed if they were not normally distributed to
satisfy the necessary statistical assumptions of linear regres-
sion. Stepwise model building was used to estimate the relative
contribution of the independent variables and the variability of
the dependent variable. Data with a p value less than or equal
to 0.05 were considered statistically significant.
Results
Demographic and phenotypic characteristics. The
subjects (Table 1) had broad ranges for age, BMI and
insulin sensitivity (Fig. 1, 2, 3). Plasma measurements
of insulin, leptin, adiponectin and lipids had a broad
range, while glucose was more limited as diabetic
subjects were excluded from the study (Table 1).
Men and women were well matched for age and
BMI but differed in their distribution of body fat. Men
had a greater waist-to-hip ratio and more IAF but less
SCF. In addition, in men insulin sensitivity was lower,
glucose was higher, and both leptin and adiponectin
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Table 1. Age, body fat distribution, metabolic characteristics and lipoprotein measurement
All Men Women
n 182 76 106
Age (y) 52.5±9.9 52.7±10.4 52.4±9.7
BMI (kg/m2) 26.4±4.3 27.0±3.6 26.1±4.8
Waist-to-hip ratio 0.84±0.09 0.92±0.06 0.78±0.06**
SCF area (cm2) 218±119 187±90 240±133*
IAF area (cm2) 100±65 124±68 82±57**
SI [×10−5 min−1/(pmol/l)] 6.4±4.1 5.9±4.4 6.8±3.9*
Glucose (mmol/l) 5.43±0.45 5.59±0.45 5.31±0.41**
Insulin (pmol/l) 63.8±43.7 67.8±49.1 60.9±39.4
Leptin (ng/ml) 14.0±12.5 6.9±5.1 19.1±13.7**
Adiponectin (µg/ml) 6.6±2.8 5.4±2.3 7.4±2.9**
Triglycerides (mmol/l) 1.39±0.87 1.42±1.0 1.36±0.78
HDL cholesterol (mmol/l) 1.34±0.36 1.15±0.24 1.48±0.36**
LDL cholesterol (mmol/l) 3.24±0.74 3.29±0.73 3.2±0.74
Apolipoprotein B (mmol/l) 0.97±0.23 0.99±0.23 0.97±0.23
Rf 0.276±0.031 0.262±0.032 0.286±0.02**6
Data are means±SD
* p<0.05, ** p<0.001 versus men.
Lipoprotein measurements were not available in 12 subjects with Rf not being available in an additional 8 individuals
Fig. 1A, B. Relationship between adiponectin concentrations
and insulin sensitivity in 182 subjects (A). The linear correla-
tion between these two variables is maintained when subjects
are subdivided based on sex [76 men (filled diamonds)/106
women (crosses)] (B)
Fig. 4A–C. Distribution plots of adiponectin concentrations in
all subjects (A), and in men (B) and women (C) separately. In
all instances adiponectin concentrations are normally distribut-
ed (p values 0.359, 0.680 and 0.096 by the Kolmogorov-Smir-
nov test, respectively)
concentrations were lower. HDL cholesterol and the
relative flotation index (Rf), a measure of LDL parti-
cle buoyancy, were also lower in men (Table 1).
Relationship of adiponectin concentrations with insu-
lin sensitivity. Using the Kolmogorov-Smirnov test,
adiponectin concentrations were normally distributed
in this apparently healthy cohort (Fig. 4 A; p=0.359)
and when men (Fig. 4B; p=0.680) and women
(Fig. 4C; p=0.096) were examined separately. Insulin
sensitivity, quantified as SI, was positively correlated
with adiponectin concentrations in the whole cohort
(r=0.375, p<0.0001; Fig. 1A) and when examined by
sex (men: r=0.297, p<0.01; women: r=0.410,
p<0.0001; Fig. 1B).
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Fig. 2A–J. Relationship between adiponectin concentrations
and measures of body size and body fat distribution in 182
subjects. Body size was quantified as BMI (A) while body fat
distribution was quantified as waist-to-hip ratio (B), IAF area
(C) and SCF area (D). The strongest correlation is with waist-
to-hip ratio, but this is largely the result of the sex-based dif-
ference in this ratio. These relationships between adiponectin
concentrations and the measures of body size and body fat dis-
tribution are maintained when subjects are subdivided based
on sex [F–I; 76 men (filled diamonds) and 106 women (cross-
es)], except for the relationship with waist-to-hip ratio. The re-
lationship between adiponectin and leptin concentrations has
been illustrated (E). While no relationship is observed when
the whole cohort is examined, subdivision by sex shows a rela-
tionship between the two peptides in men and women (J)
Fig. 3A, B. Relationship between adiponectin concentrations
and age in 182 subjects (A). The linear correlation between
these two variables is maintained when subjects are subdivid-
ed based on sex [76 men (filled diamonds)/106 women (cross-
es)] (B)
Relationship of adiponectin concentrations with body
fat distribution and plasma leptin concentrations.
Simple regression analysis was used to initially exam-
ine the relationship between adiponectin concentra-
tions and body fat distribution. The relationships be-
tween adiponectin concentrations and BMI, waist-to-
hip ratio, and SCF and IAF areas were inverse
(Fig. 2A–D). The highest correlation coefficient was
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Table 2. Body fat distribution and fasting plasma adiponectin
concentrations in a subgroup of men and women matched for
age and IAF area
Men Women
n 64 64
Age (y) 52.8±10.4 54.5±9.3
BMI (kg/m2) 26.4±3.4 27.7±4.8
Waist/hip ratio 0.91±0.06 0.80±0.06**
SCF area (cm2) 172±82 288±132**
IAF area (cm2) 109±59 106±58
SI [×10−5 min−1/(pmol/l)] 6.4±4.5 5.8±4.0
Glucose (mmol/l) 5.56±0.46 5.35±0.44*
Insulin (pmol/l) 61.4±36.3 71.3±43.9
Leptin (ng/ml) 6.1±4.5 22.6±13.6**
Adiponectin (µg/ml) 5.6±2.4 7.5±3.0**
Data are means±SD
* p<0.01, ** p<0.001 versus men
observed for the relationship of waist-to-hip ratio with
adiponectin (r=−0.360, p<0.0001) followed by IAF
(r=−0.350, p<0.0001), BMI (r=−0.333, p<0.0001),
and SCF (r=−0.168, p<0.05). The correlation between
waist-to-hip ratio and adiponectin concentrations was
largely the result of the sex-based difference in this
measure of body fat distribution (Fig. 2G).
As adiponectin and leptin are both adipocyte-de-
rived proteins, we also examined the relationship be-
tween them (Fig. 2E). Despite the fact that they are
both derived from adipocytes, we did not observe a
correlation between these two parameters in the whole
cohort (r=−0.05), although there was a negative corre-
lation when the subjects were subdivided by sex (men:
r=−0.239, p<0.05; women: r=−0.278, p<0.01; Fig. 2J).
Relationship of sex and age to adiponectin concentra-
tions. Simple regression analyses examining the sex-
based relationship between plasma adiponectin con-
centrations and insulin sensitivity (Fig. 1B) and body
fat distribution (Fig. 2F–I) were also carried out. The
slopes of the regression lines were similar, but it is ap-
parent that women have higher adiponectin concentra-
tions than men for similar values for each of the inde-
pendent variables. The distribution plots of adiponec-
tin concentrations (Fig. 4B, C) also illustrate that con-
centrations are higher in women than in men.
To examine this apparent sex difference further, we
pair matched men and women for age and IAF area.
We chose to match for IAF because this measure was
more highly correlated with adiponectin concentra-
tions than was SCF (Fig. 2C, D). By definition, IAF
was similar in the two subgroups which were both
comprised of 64 individuals (Table 2). In addition, the
groups did not differ for age, BMI or insulin sensitivi-
ty. Despite these similarities, women had higher adip-
onectin concentrations than men, indicating a sex ef-
fect that could not be explained by the variables most
strongly associated with adiponectin.
To assess the relationship between age and adip-
onectin concentrations, we carried out simple linear
regression. Interestingly, while aging is associated
with an increase in IAF and a decrease in insulin sen-
sitivity we observed an increase in adiponectin con-
centrations (r=0.227, p<0.01; Fig. 3A), which existed
in both sexes (men: r=0.333, p<0.01; women:
r=0.201, p<0.05; Fig. 3B).
To further examine the impact of age on adiponec-
tin concentrations, we divided the cohort into younger
(≤51 years) and older (>51 years) groups. The groups
were well matched for sex but differed in age by 16
years (Table 3). While their BMI was similar, the old-
er individuals had more central body fat distribution,
more IAF and were more insulin resistant. Despite
these differences, adiponectin concentrations were
greater in the older subjects. The importance of age
was even more apparent in a subgroup analysis com-
paring young and older subjects matched for IAF
(97±55 vs 98±54 cm2) and sex (30 men/37 women in
each group). The two groups differed by 16 years of
age (p<0.0001), but had similar insulin sensitivity,
BMI, waist-to-hip ratio, SCF and leptin concentra-
tions. Nonetheless, the adiponectin concentrations
were 5.5±2.8 µg/ml in the young subjects and
7.3±3.0 µg/ml in the older subgroup (p<0.001).
To analyze the association between adiponectin
concentrations and age, sex and measures of body fat
distribution simultaneously, we carried out multiple
linear regression (Table 4). Adiponectin concentra-
tions were positively correlated with age and female
gender, while the correlation with IAF was inverse.
BMI and SCF did not contribute independently to the
variation in adiponectin concentrations. In this regres-
sion model, the independent variables explained 29%
of the variance in adiponectin concentrations. By step-
wise regression analysis of the same variables, IAF
accounted for 12% of the variance in adiponectin con-
centrations, while age and sex explained 11% and 5%
Table 3. Adiponectin concentrations, body fat distribution and
metabolic characteristics of subjects, subdivided by age
Young Old
n (men/women) 94 (38/56) 88 (38/50)
Age (y) 44.6±4.7 61.0±6.4***
BMI (kg/m2) 26.0±3.9 26.9±4.7
Waist-to-hip ratio 0.81±0.09 0.86±0.09***
SCF area (cm2) 201±105 236±131
IAF area (cm2) 82±55 119±70***
SI [×10−5 min−1/(pmol/l)] 7.1±4.3 5.7±3.9**
Glucose (mmol/l) 5.38±0.41 5.47±0.48
Insulin (pmol/l) 59.2±37.8 68.7±49.0
Leptin (ng/ml) 12.9±11.2 15.1±13.7
Adiponectin (µg/ml) 6.1±2.8 7.1±2.8
Data are means±SD
* p<0.05, ** p<0.01, *** p<0.001 vs young
of its variance, respectively. Thus, these analyses con-
firm our findings from the sex and age subgroup ana-
lyses and show that age and sex are determinants of
adiponectin concentrations independent of body fat
distribution.
Relationship of insulin sensitivity with body fat dis-
tribution and adiponectin concentrations. We have
previously shown that IAF is the major determinant
of insulin sensitivity, while BMI and SCF did not
contribute independently to SI when examined to-
gether. To examine whether adiponectin is correlated
with SI independently of IAF, we inserted adiponec-
tin into the multiple regression analysis of SI versus
age, sex and measures of body fat distribution (Ta-
ble 5). By stepwise regression analysis of the same
variables, IAF accounted for 41% of the variance in
SI, with an additional 3% being explained by adip-
onectin.
Relationship of plasma lipoproteins to adiponectin
concentrations. The analysis of the relationships be-
tween adiponectin and lipoproteins showed that plas-
ma adiponectin was positively correlated with HDL
cholesterol and the measure of LDL buoyancy Rf,
while it was negatively correlated with plasma tri-
glycerides (Fig. 5). No correlation was observed with
LDL cholesterol or apoB. The correlation of adip-
onectin with HDL cholesterol was the strongest, with
adiponectin explaining 37% of the variance in HDL
cholesterol. These relationships were not affected by
sex.
To determine whether the association between ad-
iponectin and triglycerides, HDL cholesterol and Rf
could replace body fat distribution and insulin sensi-
tivity as predictors of these lipids, we carried out mul-
tiple linear regression analysis. Adiponectin was
strongly positively correlated with HDL cholesterol
and Rf, independently from IAF, which contributed to
a lesser extent to these lipoproteins (Table 6). Tri-
glycerides were also independently inversely correlat-
ed with adiponectin, although its association with IAF
seemed stronger.
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Table 4. Multiple linear regression analysis of the relationship
between adiponectin concentrations and age, sex and measures
of body fat distribution
Independent Coefficient Standard p value
variables error
Age 0.084 0.019 <0.0001
Sex 1.368 0.457 0.003
BMI –0.115 0.084 0.17
SCF area 0.001 0.003 0.77
IAF area −0.011 0.004 0.009
Intercept 5.331 2.096 0.01
The dependent variable is adiponectin. The model r2 is 0.287.
Sex was coded (0, 1) with the higher number indicating female
gender. Significant regression coefficients are indicated in bold
Table 5. Multiple linear regression analysis of the relationship
between SI and age, sex, measures of body fat distribution and
adiponectin concentrations
Independent Coefficient Standard p value
variables error
Age −0.008 0.004 0.051
Sex −0.024 0.092 0.80
BMI −0.006 0.017 0.72
SCF area −0.001 0.001 0.12
IAF area −0.004 0.001 <0.0001
Adiponectin 0.054 0.015 0.0003
Intercept 2.014 0.420 <0.0001
The dependent variable is loge SI. The model r2 is 0.479. Sex
was coded (0, 1) with the higher number indicating female
gender. Significant regression coefficients are indicated in bold
Fig. 5A–J. Relationship between plasma lipoproteins and adip-
onectin concentrations in 170 subjects. This relationship was
examined for triglycerides (A), HDL cholesterol (B), LDL cho-
lesterol (C) apoB (D) and the relative flotation index (Rf) as a
marker of LDL buoyancy (E). Adiponectin is strongly correlat-
ed with both HDL cholesterol and Rf and is also inversely cor-
related with triglycerides. All these relationships are maintained
when the subjects are subdivided based on gender (F, G, J).
Discussion
Adiponectin has been postulated to be an important
mediator of the interaction between adiposity and in-
sulin sensitivity. In this large cohort of apparently
healthy subjects, we examined the relationships be-
tween plasma adiponectin concentrations, insulin sen-
sitivity, body fat distribution and plasma lipoproteins
and the impact of age and sex. While our study is
cross-sectional and therefore does not establish cause
and effect relationships, we observed a number of in-
teresting associations. We found that plasma adip-
onectin concentrations are positively correlated with
insulin sensitivity while body size and intra-abdomi-
nal fat distribution are negatively related to its circu-
lating concentrations. Further, adiponectin concentra-
tions correlate strongly with the concentration of HDL
cholesterol and LDL particle size.
It has previously been reported that insulin sensi-
tivity based on a clamp measurement and adiponectin
are related, although for analysis purposes both these
variables were log transformed because their distribu-
tion was not normal [30]. In this study we have not
carried out such a transformation as adiponectin con-
centrations were normally distributed, perhaps be-
cause our population had broad ranges of age and
body anthropometry. Our finding of a positive rela-
tionship between adiponectin and insulin sensitivity
supports the notion that adiponectin concentrations
could modulate insulin action. This finding is support-
ed by studies in heterozygous and homozygous adip-
onectin null mice which showed a dose-dependent ef-
fect of adiponectin deficiency on insulin sensitivity
[38]. Further, administration of adiponectin reduced
insulin resistance in mice that are genetically predis-
posed to obesity and diabetes by enhancing fatty acid
oxidation resulting in reduced circulating NEFA con-
centrations and tissue triglyceride content [21] and by
augmenting insulin’s ability to suppress hepatic glu-
cose production [52, 53].
The finding of an inverse relationship between
BMI and adiponectin concentrations is in keeping
with previous reports in Japanese subjects [28], Pima
Indians and Caucasians [30]. We have now found that
central obesity and intra-abdominal fat accumulation
are associated with declining adiponectin concentra-
tions. The nature of this relationship was similar in
men and women. These findings are in keeping with
the recent observation that cultured adipocytes derived
from the intra-abdominal fat depot secrete adiponectin
more actively than subcutaneous fat derived adipo-
cytes [54].
Our observations regarding the impact of sex sug-
gest that adiponectin production is also related to fac-
tors independent of body fat distribution. At any par-
ticular body size or body fat distribution, adiponectin
concentrations are greater in women than in men. Fur-
ther, in men and women pair-matched for age, BMI,
IAF and insulin sensitivity, adiponectin concentrations
were greater in women. In addition, in a multiple lin-
ear regression analysis that included body size and
body fat distribution, sex again had an independent ef-
fect on adiponectin concentrations. This finding of a
sex-based difference in plasma adiponectin concentra-
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Table 6. Multiple linear regression analysis of the relationship between lipoprotein concentrations and age, gender, measures of
body fat distribution, insulin sensitivity and adiponectin
Independent variables Dependent variables
Triglycerides HDL cholesterol LDL cholesterol Apo B Rf
Age −0.001 0.003 0.489 0.367 −0.0001
0.77 0.13 0.04 0.049 0.89
Sex 0.177 0.103 −7.720 −0.748 0.037
0.07 0.008 0.15 0.86 0.07
BMI −0.028 −0.009 −2.952 −2.356 0.002
0.11 0.22 0.003 0.002 0.51
SCF area 0.001 0.0003 0.115 0.079 0.0001
0.13 0.26 0.0007 0.002 0.90
IAF area 0.003 −0.001 0.061 0.122 −0.001
0.0003 0.01 0.23 0.002 0.003
SI −0.024 0.008 −0.845 −0.692 0.004
0.21 0.27 0.42 0.39 0.35
Adiponectin −0.039 0.036 −0.348 −0.635 0.013
0.02 <0.0001 0.70 0.36 0.0002
Intercept 5.172 3.707 156.191 117.741 −1.414
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001
The dependent variables are loge triglycerides (model r2 0.269),
loge HDL cholesterol (model r2 0.508), LDL cholesterol (model
r2 0.153), apolipoprotein B (model r2 0.245) and loge Rf. (mod-
el r2 0.355). Sex was coded (0, 1) with the higher number indi-
cating female gender. Significant regression coefficients are in-
dicated in bold and are followed by their p value in italic
tions is supported by some [28, 31, 55] but not all [30,
56] other studies. However, the current findings are
the first to account for the known sex-based differ-
ences in body fat distributions and strongly support
the concept that sex has an additional independent ef-
fect to modulate adiponectin concentrations. The
number of fat cells and fat cell size, both of which
vary between sexes, are possible determinants of adip-
onectin production rates. Furthermore, it was recently
reported that androgens decrease plasma adiponectin
concentrations in vivo as well as adiponectin secretion
from 3T3-L1 adipocytes in vitro [55].
In this cohort of subjects with a broad age range,
we observed increasing adiponectin concentrations
with increasing age. Normal aging is associated with
the development of insulin resistance [57, 58] and in-
creased fat accumulation in the central and predomi-
nantly in the intra-abdominal depot [59, 60]. These
changes would be predicted to be associated with a
decline in adiponectin concentrations with age, yet we
observed the opposite. Sex steroids could be responsi-
ble for some of these changes as both testosterone
[55] and estrogen have been shown to inhibit adip-
onectin production [61] and they both decline with
age. A reduction in adiponectin clearance in older in-
dividuals is another possible contributor to the age-
related increase in adiponectin. However, at this time,
no information is available regarding the mecha-
nism(s) of adiponectin clearance in humans or ani-
mals. Alternatively, our findings could also be ex-
plained by the selection of subjects in our study. If
low adiponectin concentrations are predictive of the
development of diabetes [37, 62], it is conceivable
that older subjects with low adiponectin concentra-
tions were excluded from our study because they were
hyperglycaemic.
It is well recognized that dyslipidaemia is associat-
ed with central obesity and insulin resistance [63]. In
this study we found that both IAF and adiponectin
were major correlates of plasma lipoproteins, in par-
ticular of LDL buoyancy (Rf) and HDL cholesterol
concentrations, in keeping with other reports [31, 34,
64]. These relationships could be mediated by effects
of adiponectin on hepatic lipase activity, which is in-
creased in central obesity and insulin resistance states
associated with the metabolic syndrome [65, 66].
While hepatic lipase does not seem to be acutely regu-
lated by insulin [67], it could be increased by reduced
adiponectin concentrations. The adverse lipoprotein
profile is likely to be only one aspect of the cardiovas-
cular risk associated with low adiponectin concentra-
tions in humans. In mice, the deletion of the adiponec-
tin gene is associated with insulin resistance and neo-
intimal hyperplasia [38]. Further, in vitro adiponectin
inhibits monocyte adhesion to endothelial cells likely
by reducing the TNF-α mediated inflammatory re-
sponse [68] and decreasing macrophage to foam cell
transformation [69]. Thus, it is possible that decreased
adiponectin concentrations play a critical role in the
pathogenesis of atherosclerosis via various mecha-
nisms.
Based on the findings in this study and those made
by others in both humans and animals, we have devel-
oped two models to explain; (i) the regulation of adip-
onectin production and (ii) the effects of adiponectin
on glucose and lipid metabolism. Adiponectin seems
to be produced and secreted exclusively by adipocytes
[23, 35, 70], predominantly in the intra-abdominal
compartment (Fig. 6A). This IAF depot is an impor-
tant determinant of insulin sensitivity [11], which
could in part be mediated by adiponectin’s effect to
enhance insulin action. Both age and female sex were
independently associated with increased adiponectin
concentrations. However, increasing age itself can re-
duce insulin sensitivity whereas female sex tends to
enhance insulin sensitivity primarily by altering cen-
tral body fat distribution.
IAF is a major source of adiponectin and NEFA
(Fig. 6B). An increase in this fat depot will decrease
adiponectin and increase NEFA, which in turn will re-
sult in an antagonism of insulin’s effects in liver and
peripheral tissues, primarily muscle. As adiponectin
enhances insulin’s effect to suppress hepatic glucose
production, reduced adiponectin will decrease the ef-
fect of insulin to inhibit hepatic glucose production. In
addition, we hypothesize that with low adiponectin
concentrations and resultant hepatic insulin resistance,
hepatic lipase activity will increase leading to a reduc-
tion in HDL cholesterol and a decrease in LDL buoy-
ancy, two critical features of the metabolic syndrome
and increased atherogenic risk. This hepatic insulin re-
sistance and increased plasma NEFA concentrations
will shift the fate of apolipoprotein B away from deg-
radation towards secretion by the liver, resulting in in-
creased triglyceride concentrations [20]. Finally, a re-
duction in adiponectin concentrations would be antici-
pated to impair insulin action in the peripheral tissues
resulting in less efficient glucose uptake and the depo-
sition of triglyceride in the muscle [27].
In summary, we have examined the relationship be-
tween adiponectin and body fat distribution in appar-
ently healthy subjects and have found evidence to sug-
gest that plasma adiponectin is more closely related to
IAF than SCF and that it could be an intermediate in
the relationship between visceral obesity and insulin
resistance. Further, from these cross-sectional data we
have found evidence that age and sex may have ef-
fects independent of IAF to determine adiponectin
production. Finally, the relationship between adip-
onectin and plasma lipoproteins suggests that a reduc-
tion in adiponectin concentrations is associated with
decreased HDL cholesterol and small dense LDL par-
ticles, an event likely mediated via an increase in he-
patic lipase activity.
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